
Opinion|Videos|February 23, 2026
Final Perspectives on APP Contributions to Alzheimer Disease Care
Author(s)Ken Cohen, MD, FACP
Panelists discuss how APPs are essential leaders shaping the future of Alzheimer disease care.
Advertisement
Episodes in this series

Panelists discuss how the Alzheimer care landscape continues to evolve, positioning advanced practice providers (APPs) as central figures in its transformation. Their leadership spans early detection, therapy delivery, and caregiver support.
Panelists discuss how continuous education and collaboration will remain critical as new treatments and technologies emerge. The panel underscores the need for APP empowerment to maintain quality amid rapid scientific change.
Panelists discuss how their collective contributions redefine Alzheimer care as a collaborative, patient-focused endeavor grounded in accessibility, empathy, and innovation.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
MFN Drug Agreements Could Raise Prices Worldwide
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
5
